Keyphrases
Lymphocytes
100%
C-C Chemokine Receptor Type 5 (CCR5)
100%
Glioma
100%
CCR2
100%
Synergize
100%
Co-inhibition
100%
Anti-PD-1 Therapy
100%
Brain Tumor
66%
Immunosuppression
66%
Infiltration
66%
Myeloid Cells
66%
Checkpoint Blockade
66%
Myeloid-derived Suppressor Cells
66%
Glioblastoma
33%
Murine Model
33%
Clinical Efficacy
33%
Antitumor Efficacy
33%
T Cell Activation
33%
Tumor Subtype
33%
Multiple Tumors
33%
CD8+ T Cells
33%
Cancer Treatment
33%
Tumor Microenvironment
33%
Cytokine Secretion
33%
Antitumor Immune Response
33%
T Cell Subsets
33%
Chemokine Receptor CCR2
33%
Immunosuppressive Myeloid Cells
33%
Modulating Agent
33%
Immunosuppressive Cells
33%
Tumor-infiltrating CD8 T Cells
33%
Monocytic MDSC
33%
CCR5 Blockade
33%
Medicine and Dentistry
Neoplasm
100%
Lymphocyte
100%
Ganglioglioma
100%
Immunosuppressive Drug
100%
Myeloid Cell
100%
Immunotherapy
66%
Immunosuppressive Treatment
66%
Cytotoxic T-Cell
66%
Brain Tumor
66%
Myeloid-Derived Suppressor Cell
66%
Proteus Syndrome
33%
Immune Response
33%
Glioblastoma
33%
Tumor Microenvironment
33%
Cancer Treatment
33%
T Cell Subset
33%
Cell Activity
33%
Cytokine Release
33%
Chemokine Receptor CCR5
33%
Chemokine Receptor CCR2
33%
Immunology and Microbiology
CCR5
100%
Myeloid
100%
Immunosuppressive Drug
100%
CCR2
100%
Lymphocyte
42%
Immunotherapy
28%
Immunosuppression
28%
Cytotoxic T-Cell
28%
Myeloid-Derived Suppressor Cell
28%
Immune Response
14%
Cell Activity
14%
Cytokine Release
14%
Chemokine Receptor CCR2
14%
Chemokine Receptor CCR5
14%
T Cell Subset
14%